BCM
PAHC icon

Bridgeway Capital Management’s Phibro Animal Health PAHC Stock Holding History

Bridgeway Capital Management’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-92,593
Closed -$2.36M – 1259
2025
Q2 		$2.36M Hold
92,593
– – 0.06% 459
2025
Q1 		$1.98M Buy
92,593
+37,593
+68% +$840K 0.05% 501
2024
Q4 		$1.16M Buy
+55,000
New +$1.27M 0.03% 636
2021
Q1 		– Sell
-12,500
Closed -$243K – 1393
2020
Q4 		$243K Sell
12,500
-9,000
-42% -$166K 0.01% 1169
2020
Q3 		$374K Buy
+21,500
New +$459K 0.01% 993

Other funds holding PAHC

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bridgeway Capital Management's PAHC Position: Q3 2025 in Review

Bridgeway Capital Management sold out of Phibro Animal Health (PAHC) in Q3 2025, closing a stake of 92,593 shares — an estimated $2.36M sold.

Bridgeway Capital Management first reported a position in PAHC in Q3 2020 and held it in 5 quarters. The position peaked at $2.36M in Q2 2025. 218 funds tracked by Wall St. Rank hold PAHC as of Q3 2025.

  • Bridgeway Capital Management reported no remaining Phibro Animal Health position as of Q3 2025 after selling out during the quarter.
  • Bridgeway Capital Management sold 92,593 Phibro Animal Health shares in Q3 2025, an estimated $2.36M.
  • Bridgeway Capital Management first reported a position in Phibro Animal Health in Q3 2020 and held it in 5 quarters.
  • Bridgeway Capital Management's Phibro Animal Health position peaked at $2.36M in Q2 2025.
  • 218 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2025.

Based on Bridgeway Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.